Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-005760

Options or other derivatives

  • Director acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Powell Andrew Kenneth William Director 2017-01-25 Grant or award · Stock Option (right to buy) +16,000 16,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…